Advances with Long Non-Coding RNAs in Alzheimer's Disease as Peripheral Biomarker

Research output: Contribution to journalReview articlepeer-review

Abstract

One of the most compelling needs in the study of Alzheimer's disease (AD) is the characterization of cognitive decline peripheral biomarkers. In this context, the theme of altered RNA processing has emerged as a contributing factor to AD. In particular, the significant role of long non-coding RNAs (lncRNAs) associated to AD is opening new perspectives in AD research. This class of RNAs may offer numerous starting points for new investigations about pathogenic mechanisms and, in particular, about peripheral biomarkers. Indeed, altered lncRNA signatures are emerging as potential diagnostic biomarkers. In this review, we have collected and fully explored all the presented data about lncRNAs and AD in the peripheral system to offer an overview about this class of non-coding RNAs and their possible role in AD.

Original languageEnglish
JournalGenes
Volume12
Issue number8
DOIs
Publication statusPublished - Jul 24 2021

Fingerprint

Dive into the research topics of 'Advances with Long Non-Coding RNAs in Alzheimer's Disease as Peripheral Biomarker'. Together they form a unique fingerprint.

Cite this